Home > Insider Trading > Filing (0001179110-15-012106)

Filing Details

Accession Number:: 0001179110-15-012106
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-08-13 19:51:43
Reporting Period:: 2015-08-11

Filing Date:: 2015-08-13
Accepted Time:: 2015-08-13 19:51:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1423824	Alder Biopharmaceuticals Inc	ALDR	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1605672	L.p. Ix Associates Srb	13355 Noel Road Suite 1350 Dallas TX 75240	No	No	No	Yes
1605673	L.p. Ix Fund Rosen Sevin	13355 Noel Road, Suite 1350 Dallas TX 75240	No	No	No	Yes
1605739	L.p. Fund Affiliates Ix Rosen Sevin	13355 Noel Road, Suite 1350 Dallas TX 75240	No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-08-11	115,358	$40.40	1,909,079	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-08-12	97,109	$40.03	1,811,970	No	4	S	Indirect	See Footnote
Comon Stock	Disposition	2015-08-12	1,795,752	$0.00	16,218	No	4	J	Indirect	See Footnote
Common Stock	Acquisiton	2015-08-12	42	$0.00	88	No	4	J	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	J	Indirect	See Footnote
No	4	J	Direct

Footnotes

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.90 to $40.00 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities And Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Total Common Shares of 1,909,079 represents 1,860,948 shares owned directly by Sevin Rosen Fund IX L.P. ("SRFIX") and 48,131 shares owned directly by Sevin Rosen IX Affiliates Fund L.P. ("SRFIX AFF"). SRB Associates IX L.P. ("SRBAIX") is the general partner of SRFIX and SRIX AFF, and in that capacity has shared voting and dispositive power over such shares. SRBAIX disclaims beneficial ownership of such shares except to the extent of its pecuniary interest.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.26 to $40.00 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities And Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Total Common Shares of 1,811,970 represents 1,765,877 shares owned directly by SRFIX and 46,093 shares owned directly by SRFIX AFF. SRBAIX is the general partner of SRFIX and SRIX AFF, and in that capacity has shared voting and dispositive power over such shares. SRBAIX disclaims beneficial ownership of such shares except to the extent of its pecuniary interest.
Represents a pro-rata in-kind distribution, without additional consideration, of 1,750,000 shares of Common Stock of the Issuer by SRFIX and 45,752 shares of Common Stock of the Issuer by SRIXAFF.
Total Common Shares of 16,218 represents 15,877 shares owned directly by SRFIX and 341 shares owned directly by SRIX AFF. SRBAIX is the general partner of SRFIX and SRIX AFF, and in that capacity has shared voting and dispositive power over such shares. SRBAIX disclaims beneficial ownership of such shares except to the extent of its pecuniary interest.
Represents the receipt of shares by SRBAIX of Common Stock of the Issuer by virtue of the pro-rata in-kind distribution described in footnote (5) above.